Appletree CI Group
- Company typePrivate
- Founded1992
- HeadquartersWinterthur, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
Appletree CI Group firmographics
Firmographics- Name
- Appletree CI Group
- Legal name
- TFS HealthScience
- Website
- https://appletree-cig.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where Appletree CI Group is headquartered
LocationHeadquarters
- HQ city
- Winterthur
- HQ country
- Switzerland
- HQ region
- Europe
Markets served
Appletree CI Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Development Services: Full-service clinical development capabilities including Phase I-III trials and Phase IV & RWE studies. Services cover regulatory strategy, clinical operations, and post-authorization studies.
- Strategic Resourcing Solutions: Flexible staffing and recruitment services providing high-quality performance, expertise, and dedication for insourcing from single critical needs to fully managed teams.
- Functional Services (FSP): Fit-for-purpose FSP outsourcing models for clinical workforce management, from global end-to-end clinical development to single service provision.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise CRO services - customized solutions |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Appletree CI Group product offering
Product offeringCore offering
TFS HealthScience is a global Contract Research Organization (CRO) that delivers tailored clinical development and resource solutions to biotech and pharmaceutical companies. Core offerings include full-service Phase I-III clinical trials, Phase IV and Real World Evidence studies, Strategic Resourcing Solutions, Functional Services (FSP), and decentralized/virtual study execution. Services are specialized across five therapeutic areas: Dermatology, Internal Medicine, Neuroscience, Oncology, and Ophthalmology.
Product overview
TFS HealthScience is a global Contract Research Organization (CRO) offering a unified, full-service clinical development platform. The portfolio consists of three core service lines: Clinical Development (covering Phase I-III and Phase IV/RWE), Strategic Resourcing Solutions, and Functional Services (FSP). These are complemented by specialized therapeutic expertise in Dermatology, Internal Medicine, Neuroscience, Oncology, and Ophthalmology. Additional capabilities include Virtual Studies/Decentralized Solutions for remote clinical trials and Expert & Talent Solutions for advisory and project support. The company positions itself as a mid-size CRO combining the global reach and full-service capabilities of a large CRO with flexibility and personal approach.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Development (Phase I-III) Full-service clinical development solutions spanning regulatory strategy and clinical operations for Phase I-III trials, delivered by scientific and operational experts for biotech and pharmaceutical sponsors.
- Phase IV & Real World Evidence (RWE) Phase IV trials and real-world evidence studies that bridge clinical trials with clinical practice, leveraging 20+ years of experience designing and running global non-interventional studies at nearly 7,000 sites worldwide.
- Strategic Resourcing Solutions Flexible staffing and recruitment services providing high-quality performance, expertise, and dedication to bring products to market faster, ranging from single critical needs to fully managed team insourcing.
- Functional Services (FSP) Fit-for-purpose Functional Service Provision (FSP) outsourcing models for global end-to-end clinical development or single services, approaching clinical workforce management efficiently and cost-effectively.
- Expert & Talent Solutions (TFS Connectify) Network of key opinion leaders, subject matter experts, and industry-leading talent available for advisory or project support, helping with critical business decisions and delivery of key project milestones.
- Dermatology CRO Services Specialized CRO services for dermatology indications including eczema, psoriasis, and melanoma, offering comprehensive clinical development expertise across skin conditions.
- Internal Medicine CRO Services CRO expertise encompassing a broad range of internal health conditions, providing holistic and integrated clinical development tailored to each project's unique needs.
- Neuroscience CRO Services CRO services for complex neurological and psychiatric disorders, providing clinical development informed by extensive experience in neuroscience indications.
- Oncology CRO Services End-to-end oncology clinical development solutions, from regulatory strategy selection to designing efficient studies and executing high-quality cancer clinical trials.
- Ophthalmology CRO Services Clinical development and commercialization services for ophthalmology drugs, devices, and diagnostics, dedicated to advancing eye health and vision care.
Quantifiable outcome
- Nearly 7,000 sites worldwide for global non-interventional studies
- +2 more outcomes
Companies that use Appletree CI Group
Customer profileSegments2 records
Ideal customer profiles2 records
Appletree CI Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Appletree CI Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- VERIGRAFTcoreTFS HealthScience and VERIGRAFT announced a partnership to advance P-TEV (personalized tissue-engineered vein) through pivotal Phase II/III trial in chronic venous insufficiency. TFS provides clinical development expertise and operational support for the trial.
Scale indicators3 records
Recent moves4 records
Expansion highlights5 records
Appletree CI Group competitors and assessment
Company assessmentDirect peers
- Syneos Health: Global CRO offering full-service clinical development and FSP solutions to biopharma sponsors. Directly comparable to TFS across service portfolio and sponsor base, though at larger scale.
- Medpace: Mid-size global CRO with strong therapeutic-area specialization and a 'full-service' operating model. Closely comparable to TFS in size positioning, sponsor focus on biotech and mid-cap pharma, and emphasis on indication-specific expertise.
- Charles River Laboratories: Global CRO and preclinical services provider offering clinical development, FSP, and research models. Directly comparable to TFS in clinical development and FSP service lines with similar biopharma sponsor focus.
- Worldwide Clinical Trials: Mid-size global CRO offering full-service clinical development across multiple therapeutic areas. Directly comparable to TFS in mid-size positioning, therapeutic specialization, and biotech/pharma sponsor focus.
- Parexel International: Large global CRO offering Phase I–IV clinical development, FSP, and resourcing solutions. Closely comparable to TFS across the same service lines and biopharma sponsor base, though at materially greater scale.
Broad incumbents
- IQVIA: Largest global CRO with full-service clinical development plus proprietary RWE, technology, and data assets. Competes with TFS in clinical development and RWE but is many times TFS's size with broader, more diversified offerings.
- ICON plc: One of the world's largest CROs offering full-service clinical development, FSP, laboratory, and decentralized trial capabilities. Overlaps substantially with TFS's full-service and FSP offerings but operates at significantly larger scale across a broader portfolio.
- Labcorp Drug Development (Covance): Large CRO offering clinical development, central laboratory, and FSP services. Comparable to TFS in clinical operations and FSP delivery but at substantially greater scale with integrated lab capabilities TFS does not operate.
Emerging players
- Celerion: Specialty early-phase and clinical pharmacology CRO serving biotech and pharma sponsors. Comparable to TFS in clinical research service delivery but focused on earlier-phase, smaller-scale studies.
Regional players
- WuXi AppTec: Asia-based CRO offering discovery, preclinical, and clinical development services globally. Comparable to TFS in clinical development services and biopharma sponsor focus, but with significant Asia-headquartered operations and broader discovery/preclinical footprint.
Market position
Strengths3 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Appletree CI Group social profiles
Digital presenceAppletree CI Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Appletree CI Group leadership team
Management profileNumber of profiles
Appletree CI Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Appletree CI Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Appletree CI Group
What does Appletree CI Group do?
TFS HealthScience is a global Contract Research Organization (CRO) that delivers tailored clinical development and resource solutions to biotech and pharmaceutical companies. Core offerings include full-service Phase I-III clinical trials, Phase IV and Real World Evidence studies, Strategic Resourcing Solutions, Functional Services (FSP), and decentralized/virtual study execution. Services are specialized across five therapeutic areas: Dermatology, Internal Medicine, Neuroscience, Oncology, and Ophthalmology.
Is Appletree CI Group a public or private company?
Appletree CI Group is a private company. It is classified as unknown and is currently operating.
When was Appletree CI Group founded?
Appletree CI Group was founded in 1992. It employs 11 to 50 people.
Where is Appletree CI Group based?
Appletree CI Group is headquartered in Winterthur, Switzerland, in the Europe region.
How does Appletree CI Group make money?
Three revenue lines are on record. Clinical Development Services are the primary driver. The others are strategic Resourcing Solutions and functional Services (FSP).
Who are Appletree CI Group's main competitors?
Direct peers on record are Syneos Health, Medpace, Charles River Laboratories, Worldwide Clinical Trials and Parexel International. Broad incumbents are IQVIA, ICON plc and Labcorp Drug Development (Covance). Celerion is listed as an emerging player. WuXi AppTec is listed as a regional player.
Does Appletree CI Group have an API?
No public API is recorded for Appletree CI Group.